coparion

Coparion GmbH & Co. KG is a venture capital firm based in Cologne, Germany, that specializes in early-stage investments in technology and life sciences companies across the country. Founded in 2016, Coparion manages an active fund of EUR 275 million, providing financial support to startups and early growth phase businesses. The firm typically invests between EUR 0.5 million and EUR 10 million per company, often engaging in multiple financing rounds. Coparion focuses exclusively on companies headquartered in Germany and prefers to invest alongside co-investors. The firm aims to support entrepreneurial visions with its expertise while refraining from interfering in daily business operations. By leveraging its experience in venture capital and company building, Coparion seeks to identify potential in emerging businesses and help navigate challenging situations effectively.

Stefan Martinez

Investment Manager

Sebastian Pünzeler Ph.D

Investor

Christian Schulte

Managing Director

Martin Sonntag

Investment Professional

Toba Spiegel

Investor

Christian Stein

Managing Director

David Zimmer

Managing Director

Past deals in Germany

Protembis

Series A in 2018
Protembis GmbH, founded in 2017 and based in Aachen, Germany, specializes in manufacturing surgical equipment designed to enhance patient safety during transcatheter aortic valve replacement (TAVR) procedures. The company's ProtEmbo System addresses a significant complication associated with TAVR—cerebrovascular events—by utilizing an intra-aortic filter device that deflects potential embolic material away from the brain during the valve implantation process. As TAVR technology evolves and is increasingly performed on younger, lower-risk patients, Protembis aims to reduce the risk of adverse neurological outcomes, thereby improving overall patient care and outcomes in the treatment of valvular heart disease.